Relief Therapeutics
Presence
Relief Therapeutics is one of the...
Relief Therapeutics is a company listed under the stock ticker RLFTY (CH).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Relief Therapeutics
- Michelle Lock, Director and Interim Chief Executive Officer
- Patrice Jean, Director
- Raghuram Selvaraju, Chairman of the Board
Popular executive movements at Relief Therapeutics
- Giorgio Reiner, who was Corporate Director, R&D, is promoted to Chief Scientific Officer (posted on May 9 2024).
- Jeremy Meinen, Chief Financial Officer and Treasurer, will leave the company on Jun. 1, 2024 (posted on May 9 2024).
- Andrew Einhorn has joined the company as Chief Financial Officer (posted on May 9 2024).
Click here to view some more movements at Relief Therapeutics
Create your alert
to follow the executive moves at Relief Therapeutics.
Biotechnology
Relief Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Relief Therapeutics
- newsblog-detailNews Detail - Relief Therapeutics Holdings SA
- newsblog-detailNews Detail - Relief Therapeutics Holdings SA
- newsblog-detailNews Detail - Relief Therapeutics Holdings SA
- newsblog-detailNews Detail - Relief Therapeutics Holdings SA
- newsblog-detailNews Detail - Relief Therapeutics Holdings SA
Social media about Relief Therapeutics
- Relief Therapeutics on Wikipedia, Google News & Yahoo Finance
- Relief Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Michelle Lock 
Call Relief Therapeutics at +41 44...
